Introduction
Mutations in cardiac Troponin T (TnT) have been implicated in familial hypertrophic cardiomyopathy (FHC) (1) (2) (3) (4) (5) . Individuals with cardiac TnT mutations appear to have a high incidence of sudden cardiac death at a young age, although heterozygote individuals have either little or no cardiac hypertrophy (1, 3, 4) . At present, there is no clear understanding as to why TnT mutations in particular pose a high risk for sudden death, as opposed to, for example, mutations in the myosin heavy chain, which usually cause a much greater degree of cardiac hypertrophy. Sudden cardiac death of FHC patients is often caused by ventricular tachyarrhythmias (6) , but its cause remains unknown for patients with TnT mutations. In fact, the clinical features of hypertrophic cardiomyopathy have been established mostly without knowledge of the genotype, and may not apply to patients carrying specific TnT mutations. Given the paucity of clinical information, a transgenic mouse model provides the opportunity to study the functional consequences of a TnT mutation in an in vivo system.
To investigate the mechanisms of how a TnT mutation alters cardiac function and lead to sudden cardiac death, we have generated transgenic mice expressing the human cardiac TnT-I79N mutant (Tg-I79N). Similar to humans carrying this mutation, Tg-I79N mice show no cardiac hypertrophy (7) . We found a large increase in Ca 2+ sensitivity of the skinned cardiac fibers from Tg-I79N mice compared to fibers from transgenic mice expressing human wild-type TnT (Tg-WT), but maximal developed force was significantly lower in cardiac fibers from Tg-I79N mice (7) .
In this study we examined the effect of the I79N mutation on cardiac performance and electrophysiological properties of the whole heart, in vitro and in vivo. We found that the effect of the mutant protein was dependent on the inotropic state of the heart: Under baseline conditions, systolic function was higher in Tg-I79N mice, with little effect on diastolic function. However, ] o . All perfusion buffers were equilibrated with 95% O 2 + 5% CO 2 for at least 1 hour prior to the experiment, yielding a pH of 7.4 .
Measurement of Isovolumic Cardiac Performance
A water-filled balloon custom-made of polyvinylchloride film was inserted through the mitral valve into the left ventricle via an incision in the left atrium as described (8) . A 2.0-Fr microtip transducer (Millar, Inc, Texas) was guided through the polyethylene tube and positioned inside the balloon. The balloon was inflated to adjust the end-diastolic pressure (EDP) at 6-8 mmHg, and the balloon volume was held constant for the duration of the experiment. The left-ventricular pressure was digitized at 1000 samples/s with the use of a commercially available data acquisition system (PowerLab, ADInstruments, Inc.). The fast sampling rate coupled with the use of a pressure catheter with a flat frequency response up to 10 kHz allowed us to do the detailed kinetic analysis of the pressure recordings outlined below.
The following indices of cardiac performance were measured off-line using custom-built software (National Instruments, Inc.) and averaged from three consecutive beats at baseline and at 7 LV pressure curve was fitted from the time of minimum dP/dt to a level 5 mmHg above the EDP of the next beat using an monoexponential function as described (8) .
Surface Electrocardiogram (ECG) and Systolic Blood Pressure Measurements
For the ECG measurements, mice were anesthetized either with ketamine (100 mg/kg) and xylazine (5 mg/kg), or with 20 ml/kg of 2% tribromoethanol (Avertin) via intraperitoneal (i.p.)
injection. Mice were positioned prone in a shielded box, with all four extremities immersed in 3 M KCl filled wells to reduce skin resistance. The bottom of the shielded box was heated to 37°C using a circulating water bath to maintain a stable body temperature during the experiment. In order to accurately capture the ECG signals from mice, which have the high heart rates (500-600 beats) and a very short QRS duration, a custom-built ECG amplifier (Vibraspec, Bear Island, ME 04662) was used. This amplifier provided a high frequency response and large gain (1000 Hz and 10000 fold gain) and was used to record bipolar limb leads in standard fashion as described (10). Signals were digitized at 1 kHz using a National Instruments, Inc. data acquisition system with custom-built software. For each animal, PR and QRS intervals were measured from three consecutive beats in leads I and II and averaged. For QT and RR measurements, the recordings were signal-averaged over a 30 s time interval using the peak of the R-wave as the fiduciary point as described (11). This procedure reduced the effect of respiratory and motions artifacts on QT measurements. The RR interval was measured as the average over the 30 s interval, and the QT interval was measured in the lead with the longest and most prominent T-wave.
Systolic blood pressure and heart rate were measured in conscious and anesthetized mice using a commercially available, noninvasive computerized tail-cuff system (BP-2000, Visitech, Apex, NC).
Echocardiography and Doppler Measurements
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Mice were anesthetized as for the ECG measurements and positioned supine on a heated surface (37°C) to maintain a stable body temperature during the experiment. Echocardiography and Doppler measurements were performed with a 1 cm gel standoff in a left-lateral position similar to the technique used by Hoit and colleagues (12) . An Acuson Sequoia C256 system with a linear transducer in 13 MHz mode was used to obtain high-resolution two-dimensional (2-D) and M-mode measurements (17) . )/ET) were calculated.
Isoproterenol Application
Isoproterenol was given as a bolus intraperitoneal injection after stable baseline ECG and echocardiography recordings had been obtained (5-10 minutes). Mice were initially challenged with a dose of 1.5 mg/kg (high-dose) based on reports in the literature (12) . After deaths occurred in the Tg-I79N group, we examined the effects of a lower dose (0.1 mg/kg), which was sufficient to produce a significant increase in heart rate in all 4 groups of mice. All ECG and echocardiographic assessments described above were repeated at 3-5 minutes after injection, when a significant increase in heart rate was present.
Mice Exercise Protocol
A swimming protocol described by Geisterfer-Lowrance et.al (13) was utilized to examine the effects of chronic aerobic exercise. Groups of 4 animals, 2 months old, representing the different lines, were exercised by swimming. Mice were adapted to the swimming program by beginning with 10 min sessions two times a day separated by 4 hours. These were incremented by 10 min per day until reaching 90 min per session. The program was completed in 4 weeks. During each session, they were monitored for inability to sustain the exercise and/or sudden death.
Autopsy and Histopathology of Tg-Mice
Every mouse that died during the isoproterenol challenge was autopsied to rule other causes of death such as hemorrhage. This is especially important because drugs were administered via intraperitoneal injection. One death (a non-Tg mouse) was indeed due to a hemorrhage from the right iliac artery close to the injection site. This animal was excluded from further analysis. We did not find any evidence for bleeding in any of the other deaths.
Three separate groups of mice (4 Non-Tg, 4 Tg-WT, Tg-I79N line 9), were specifically sacrificed to examine the heart morphology and histology. Two mice of each group had undergone by guest on January 8, 2018
http://www.jbc.org/ Downloaded from chronic exercise. After euthanasia, each mouse was autopsied with dissection of the heart. The heart was weighed and any gross abnormalities (chamber enlargement, mural thrombi, etc.) were recorded.
The 10% buffered formalin fixed heart was sectioned along its transverse plane and embedded in paraffin. Microscopic sections were cut from the transected surface at 4-6 µm and stained with hematoxylin and eosin (H & E) for overall morphology and Mason's trichrome (MT) for collagen.
The histologic slides were examined for the presence of asymmetric hypertrophy, fibrosis or myocyte disarray without knowledge of genotype, degree of exercise training, or in vivo test results.
Computer simulations
Force generation in Tg-WT and Tg-I79N myocardium was simulated by computer based on a modification of the model of Robertson et al. (14) and a two-state cross-bridge model (15) utilizing an exponential dependence of the TnC off-rate for Ca 2+ (Ca
2+
-specific site II) on force (16) . These simulations have been extensively described in the accompanying paper (7).
Statistical Analysis
All experiments (Left-ventricular pressure, ECG and Echocardiography) were done in random sequence in respect to the genotype, and measurements were taken by a single observer who was blinded to the genotype. Differences between groups were assessed using a one-way analysis of variance (ANOVA). If statistically significant differences were found, individual groups where compared with Student's two-sided t-test without correction for multiple comparisons. Incidence rates were compared using Chi-square test statistic. Results were considered statistically significant if the P-value was less than 0.05. Unless otherwise indicated, results are expressed as means and standard error of the mean (SEM).
Results

Cardiac Performance of the Isolated Heart
Baseline measurements
To examine the functional consequences of the I79N mutation in the whole heart, we measured indices of cardiac performance in the isolated perfused, isovolumically-contracting heart.
This experimental preparation permits exact control of the loading conditions, and has been used to examine both systolic and diastolic function in other murine models (8, (17) (18) (19) . Systolic function was assessed from systolic pressure, time to peak pressure, and maximum rate of pressure rise (+dP/dt).
Diastolic function was assessed from the maximum rate of pressure decay (-dP/dt), and from time to 90% relaxation and the time constant of isovolumic relaxation. When hearts were paced at 420 min -1 and end-diastolic pressure was set at 6-8 mmHg, systolic performance was not statistically different between Tg-I79N, Tg-WT, and non-Tg hearts (table 1) . However, the initial rise of pressure was faster in Tg-I79N hearts ( Fig. 1, arrow) . Thus, time to maximum +dP/dt was significantly shorter in the Tg-I79N hearts (table 1) . On the other hand, time to 90% relaxation and the relaxation time constant were significantly longer in the Tg-I79N hearts compared to both Tg-WT and non-Tg hearts (table 1) . The pressure tracings of Fig. 1 illustrate the slower relaxation of the Tg-I79N hearts. The ratio of +dP/dt to -dP/dt, which can be used to assess diastolic function relative to systolic function (20) , was significantly increased in Tg-I79N mice (table 1) . Furthermore, the LV balloon volume at an end-diastolic pressure of 8 mmHg was lower in Tg-I79N mice (Tg-I79N: 13.0 ± 0.3 µl, Tg-WT:
15.1 ± 0.8 µl, p<0.05).Taken together, these results indicate that Tg-I79N hearts had significantly impaired diastolic function.
Force traces were simulated as would be observed during isometric twitch contractions of Tg-WT and Tg-I79N ventricular myocardium using variables (off-rate of Ca 2+ from troponin C, and cross-bridge dissociation constant) derived previously (7) . Transgenic I79N myocardium relaxed slower than Tg-WT, which is consistent with the experimental observations in isovolumetrically beating heart.
Ca 2+ dependence of cardiac performance
We also examined the changes in cardiac performance in response to changes in [Ca
] o of 0.5 and 1 mM, developed pressure was significantly higher in Tg-I79N than in Tg-WT hearts ( Fig. 2A) ] o .
In vivo Cardiac Performance and Cardiac Electrophysiology of Tg mice
Baseline Echocardiography and Doppler measurements
Echocardiography and Doppler measurements have been used extensively to characterize the cardiac phenotype of transgenic mouse models (21) . We measured cardiac dimensions, indices of systolic function and diastolic ventricular by 2D-guided M-mode (Fig. 3A) and Doppler (Fig.   3B ). Table 2 summarizes the results. Indices of systolic contractile function (LV shortening fraction and VCFc) were significantly higher in both Tg-I79N lines compared to Tg-WT.
Evidence for increased contractility was also present on flow measurements by Doppler. Tg-I79N mice had a significantly shorter time to peak outflow velocity (Fig. 3B) . Baseline diastolic filling parameters measured by Doppler (E-wave, A-wave, E-wave deceleration time, E/A ratio) were not statistically different between all 4 lines. Thus, unlike the isolated perfused heart, systolic function was increased in Tg-I79N mice, but diastolic function appeared to be normal. One reason for this apparent discrepancy may be related to the slow heart rates (~250 min by the ketamine/xylazine anesthesia. We therefore repeated the echocardiography and Doppler measurements using a different anesthetic, Avertin, which produces much less bradycardia. Since there were no large differences in the cardiac parameters between Tg-I79N lines 8 and 9, we compared Tg-I79N line 9 with Tg-WT mice and non-Tg mice. Heart rates indeed increased to a similar extent in all groups (table 2). Systolic function was significantly different between all three groups (LV shortening fraction: Tg-I79N 43±1.2 %, Tg-WT 27±1.2 %, non-Tg 33±1.2 %, p<0.00001 by ANOVA). Interestingly, at these faster heart rates, the end-diastolic dimension was significantly smaller in Tg-I79N mice (3.2±0.1 mm, p<0.0001 against both WT and non-Tg) than in Tg-WT mice (3.8±0.1 mm) or in non-Tg mice (3.6±0.2 mm). Nevertheless, Doppler indices of diastolic filling were not significantly different. Unfortunately, the A-wave could only be measured in less than 30% of the examined animals.
To exclude the possibility that the differences in LV shortening fraction were merely due to a difference in afterload, we also measured the blood pressure in anesthetized mice (Avertin). ] for the baseline isolated heart recordings.
In another series of experiments, we examined whether the increased systolic function can be demonstrated in conscious Tg-I79N mice. Systolic blood pressure was not significantly different between Tg-I79N (112±2 mmHg, n=32) and Tg-WT mice (114±2 mmHg, n=23, p=n.s.). Heart rate, on the other hand, was significantly lower in Tg-I79N mice (521 b/min vs.
604 b/min, p<0.00001). It remains to be determined whether the slow heart rate of Tg-I79N mice represents a vagal response to the increased cardiac contractility.
ECG measurements
Cardiac arrhythmias are a potential cause of sudden death. Limb-lead ECGs were recorded from anesthetized non-Tg, Tg-WT and Tg-I79N mice (Fig. 4A) . The most significant finding was that Tg-I79N had a consistently prolonged PR interval representing the conduction time from the atria to the ventricle. The PR prolongation was independent of the anesthetic used (data not shown) and was more pronounced in chronically exercised mice (Fig. 4B ). As shown in Fig. 4C , the degree of PR prolongation appeared to be related to the expression level of the mutant TnT protein: Line 8 with higher levels of Tg-I79N had more PR prolongation than line 9 with lower protein levels.
Although PR prolongation is not a common ECG finding in FHC patients, left atrial enlargement is often observed. Left atrial hypertrophy in Tg-I79N mice was documented on autopsy. QRS duration and heart rate were not statistically different, but the QT-interval was significantly shorter in Tg-I79N mice (line 9: 43±2.6 ms, n=8, line 8: 51±6.0ms, n=5, Tg-WT: 67±4.5 ms, n=13, non-Tg:
67±2.5 ms, n=13, p<0.05 between groups). Arrhythmias were not observed in Tg-I79N mice at baseline.
In vivo cardiac performance under inotropic stimulation
Based on the results from the isolated heart studies and the simulation studies, raising (Fig. 6B ). Compared to the sustained acceleration in heart rate of Tg-WT mice, the same isoproterenol injection resulted only in a very transient increase in heart rate in Tg-I79N mice, followed by progressive conduction blocks and eventually death (Fig. 7) . The insets in Fig. 7 illustrate the profound changes in QRS morphology (progressive loss in R-wave amplitude, QRS widening and T-wave inversion) that developed after isoproterenol injection.
Ventricular tachyarrhythmias were observed only in a few mice, and were never sustained more than a few seconds. Tg-I79N mice died with progressive conduction blocks present on ECG. Autopsy examination demonstrated dilated atria with pulmonary and hepatic congestion, and no evidence for bleeding. Taken together, these data indicate that the isoproterenol-induced deaths were not caused by ventricular tachyarrhythmias. It remains to be determined whether the bradyarrhythmias were the primary cause of the deaths, or whether they were a secondary phenomenon; e.g. as a result of pulmonary edema and respiratory failure, which developed because of the isoproterenol-induced cardiac dysfunction.
Effect of chronic exercise
Eight Tg-WT, 8 Tg-I79N and 8 non-Tg mice underwent 4 weeks of chronic swimming exercise. Two deaths occurred, one each in the Tg-WT and the Tg-I79N group. No apparent difference in exercise tolerance were observed between the groups. Except for the increase in PR interval in Tg-I79N mice (Fig. 4B ), there were no other ECG abnormalities or arrhythmias found on ECG studies obtained after the completion of the exercise program.
Histopathology of Tg-mice
Hearts of Tg-I79N were smaller than age and sex-matched Tg-WT and non-Tg mice, with a significantly decreased heart weight to body weight ratio, as already reported in the preceding article (7). However, we found evidence for left atrial hypertrophy (left atrial weight Tg-I79N, line 9: 10±2 mg vs. Tg-WT: 5±1 mg, n=6 each, p=0.08), which was significantly different when the values were corrected for the lower ventricular weight of Tg-I79N mice (left atrial weight/heart weight ratio Tg-I79N: 0.048±0.009 vs. Tg-WT: 0.023±0.003, n=6 each, p=0.025). Histological examinations of hematoxylin and eosin (H+E) stained ventricular sections from non-Tg, Tg-WT (line 3) and Tg-I79N (line 9) revealed normal myocyte architecture and no major differences between the three lines (Fig. 8, upper panels) . Tg-WT (line 3) and Tg-I79N (line 9) may have somewhat more nuclear pleomorphism (greater variation in the size and appearance of the nuclei) than the non-Tg mice. On trichrome (TRIC) stained sections, which stains muscle and red blood cells red and areas containing fibrosis or collagen blue, no differences between the three lines were observed. Chronic exercise had no effect on cardiac histology in either group.
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Discussion
The major finding of this study is that significant alterations in cardiac contractile and electrical properties occur in transgenic mice carrying the TnT-I79N mutation. In the isolated heart, ] o , diastolic dysfunction became manifest as both an increase in end-diastolic pressure and in time to 90% relaxation (table 1 and Figs. 1 and 2). In vivo measurements with echocardiography and Doppler confirmed that, at baseline, systolic function was significantly higher in Tg-I79N mice without evidence for diastolic dysfunction (Table 2 and Fig. 3 ). However, inotropic stimulation with isoproterenol resulted only in a modest initial contractile response, but later caused significant mortality only in Tg-I79N mice (Figs. 6) .
Doppler studies ruled out aortic outflow obstruction and were consistent with impaired diastolic filling (table 2 and Fig. 5 ). Continuous ECG monitoring ruled out ventricular tachyarrhythmias as cause of death and showed changes in ECG morphology and bradyarrhythmias (Fig.7) .
Morphological and histological studies ruled out significant ventricular hypertrophy, fibrosis or myocyte disarray (Fig. 8) . Our results are consistent with the hypothesis that the increased myofilament Ca 2+ sensitivity due to the I79N mutation enhances baseline contractility, but leads to cardiac dysfunction under inotropic stimulation. This mechanism may contribute to excess mortality during exercise or other states with high levels of endogenous catecholamines, even in the absence of significant cardiac hypertrophy.
Cardiac Performance of Tg-I79N mice
In the isolated heart of I79N mice, systolic function was higher, and relaxation was impaired.
Although no data from humans or other transgenic models carrying the I79N mutation exist, similar findings have been reported in a mouse model expressing the FHC-linked TnT-R92Q mutation (17) (18) (19) , whereas impaired systolic function has been reported in an independently created transgenic mouse model of the same mutations (22 ] O of 2 mM, their systolic performance may actually have been underestimated in our isolated heart experiments.
Contractile indices obtained by echocardiography are significantly influenced by changes in preload and afterload. There are several reasons to believe that the reported in vivo results represent true differences in myocardial systolic performance: Afterload, as estimated by systolic blood by guest on January 8, 2018
http://www.jbc.org/ Downloaded from pressure, was not significantly different between Tg-I79N and Tg-WT. Although we did not directly measure the end-diastolic pressure (preload) in vivo, the end-diastolic LV dimensions can be used as a correlate, if heart rate and diastolic compliance are the same. End-diastolic LV dimensions were significantly smaller in the Tg-I79N mice, suggesting that either EDP was lower, or compliance was decreased in Tg-I79N mice. Thus, changes in preload are unlikely the explanation for the profound increase of the shortening fraction in the I79N mice.
In the Tg-I79N mice, ventricular relaxation was predicted to be slowed under basal conditions, based on our simulation studies, and at a [Ca
2+
] o of 2 mM or above based on the isolated heart studies (table 1 ). Yet, we did not find evidence for impaired filling on Doppler under baseline conditions. One possibility is that the Doppler technique is not sensitive enough to detect subtle increases in diastolic chamber stiffness. Another possible explanation is the relatively low free
] o (1.25 mM) in mouse blood. In the isolated heart experiments, diastolic relaxation times were not significantly different at [Ca 2+ ] o of 0.5 or 1 mM, and EDP was significantly higher in the Tg-WT compared with Tg-I79N hearts (Fig. 2B ). This increase of EDP at low [Ca 2+ ] o is somewhat surprising, but has been observed previously in the isolated heart preparation and is thought to be related to the turgor effect, when the perfusion pressure exceeds the systolic pressure during continuous retrograde perfusion (18) .
Cardiac Electrophysiology and Arrhythmias
Unlike in the MHC403-/-mouse model (23), ventricular arrhythmias were not observed in sedentary or exercised I79N mice at baseline. However, this may not be expected during the short period of ECG recordings employed in our study, since even in FHC patients ventricular arrhythmias are relatively rare, and occur on average less than 1 per month (6) .
Surprisingly, transgenic mice expressing TnT-I79N had a consistently prolonged PR interval on ECG recordings. The PR prolongation was independent of the anesthetic used, was correlated to gene-dosage (Fig. 4C) , and was more pronounced in chronically exercised (Fig. 4B) . The duration of the PR interval is determined by conduction from the atria to the ventricle, and is controlled by the autonomic nervous system. An increase in vagal tone therefore could account for the PR prolongation, and could represent a reflex mechanism to increased cardiac contractility of I79N mice (e.g., via the baroreceptor reflex). The slower heart rate of conscious I79N mice is consistent with this hypothesis. Alternatively, atrial hypertrophy has been associated with PR prolongation in other mouse models of cardiac hypertrophy (10). We found significant atrial hypertrophy in I79N mice, and this may have contributed to the PR prolongation. The atrial hypertrophy could result from atrial I79N overexpression driven by the MHC promoter, which occurs earlier in the atria than in the ventricle (24), or might be a compensatory response to impaired diastolic relaxation of the ventricle, or both. Atrial hypertrophy has also been described in mice expressing the TnT-R92Q mutation (17) .
Isoproterenol-induced contractile abnormalities, ECG Changes and Mortality
Based on our echocardiography and Doppler measurements, isoproterenol had little effect Accordingly, changes in this parameter could detect even the transient increase of diastolic chamber stiffness that occurs after coronary artery bypass surgery (26, 27) . Together with the data from the by guest on January 8, 2018
http://www.jbc.org/ Downloaded from isolated heart and the modeling studies, the significantly shortened E-wave deceleration time (table   2 and Fig. 5 ) in both transgenic lines suggests that isoproterenol induced an increased diastolic chamber stiffness in Tg-I79N mice. Obviously, an extensive cardiac catheterization study will have to confirm these observations in the future.
One surprising finding was the high mortality of Tg-I79N mice following the isoproterenol injection. Based on our Echocardiography and Doppler findings, the deaths were not caused by an aortic outflow obstruction, which is a common cause of death in end-stage human FHC (28) . Deaths were also not due to ventricular tachyarrhythmias, another major cause of death in FHC patients (6), or hemorrhage. Rather, Tg-I79N mice died after isoproterenol induced changes in ECG morphology (loss of R-wave, ST segment depression and T-wave inversion) and heart block ( It remains to be determined why excess mortality was restricted to the isoproterenol challenge under anesthesia, and did not occur during the chronic swimming exercise, which should have produced a considerable endogenous catecholamine response. This suggests that the additional cardiovascular stress of anesthesia was needed to decompensate the Tg-I79N mice. On the other hand, sudden death in response to exercise is a rare event even in patients with FHC, and our chronic swimming exercise of 4 weeks in a limited number of mice might not have been sensitive enough to demonstrate significant differences in a rare event.
Thus, in an attempt to relate our previously published results obtained from skinned fibers to the data presented here, we suggest the following potential mechanisms for the isoproterenolinduced mortality: (i) The increased Ca 2+ sensitivity of myofilaments (7) will enhance basal cardiac contractility ( Table 2 Representative heart rate response and ECG morphology after intraperitoneal (i.p.) injection of isoproterenol (1.5 mg/kg). The insets illustrate the changes in ECG morphology over time. Compared to Tg-WT mice (upper panel), Tg-I79N mice (lower panel) develop a rapid increase, followed by a progressive decrease in heart rate, which is accompanied by characteristic changes in ECG morphology (loss of R-wave, QRS widening and T-wave inversion, inset D). Tg-I79N mice then die from progressive conduction blocks (PR prolongation, and 2 nd and 3 rd degree atrioventricular block (AVB), insets E, F and G).
Figure 8 Histological examination
Hematoxylin and eosin (H+E) (upper panels) and trichrome (TRIC) (lower panels) stained ventricular sections from Non-Tg, Tg-WT (line 3) and Tg-I79N (line 9). Note normal myocyte architecture and no major differences between the three lines.
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